MAHLIFE · NSE Real Estate Large Cap

Mahindra Lifespace Developers Limited

MAHLIFE  ·  National Stock Exchange of India

MAHLIFE is currently trading at ₹380, 2.0% above its 50-day moving average. The Kasauti methodology audit finds 6 of 8 structural parameters confirmed, placing this instrument in the Close to Criteria category.

Data Execution Timestamp: 21 August 2026 · NSE Closing Bell
Overall Verdict
कसौटी के करीब
Close to Criteria
Minervini SEPA 6 / 8
Weinstein Stage Stage 2 — Advance
Base Advance Top Decline
52-Week Price History — Weekly
₹380 Snapshot · NSE Closing Bell · 21 Aug 2026
₹292 ₹328 ₹364 ₹400 ₹436 Jul '25 Oct '25 Jan '26 Apr '26 Jul '26 52W H ₹423
Weekly close 50 DMA 200 DMA 52W high

Minervini SEPA — 8 Parameter Audit

Parameter Result Data
Price above 150 & 200 DMA
Minervini SEPA · Criterion 1
PASS Price ₹380 · 150 DMA ₹351 · 200 DMA ₹362
150 DMA above 200 DMA
Minervini SEPA · Criterion 2
FAIL 150 DMA ₹351 vs 200 DMA ₹362 (-2.9%)
200 DMA trending up ≥ 1 month
Minervini SEPA · Criterion 3
PASS 200 DMA slope: +0.20% over 4 weeks
50 DMA above 150 & 200 DMA
Minervini SEPA · Criterion 4
PASS 50 DMA ₹372 · 150 DMA ₹351 · 200 DMA ₹362
Price above 50 DMA
Minervini SEPA · Criterion 5
PASS Price ₹380 · 50 DMA ₹372 (+2.0%)
Price within 25% of 52-week high
Minervini SEPA · Criterion 6
PASS ₹380 vs 52W high ₹423 (-10.2%)
Price ≥ 30% above 52-week low
Minervini SEPA · Criterion 7
PASS ₹380 vs 52W low ₹284 (+33.7%)
RS Rating ≥ 70
Minervini SEPA · Criterion 8
FAIL RS Rating: 64 (threshold: ≥70)

Weinstein Stage Analysis

Stage 1
Base
Stage 2
Advance
Stage 3
Top
Stage 4
Decline

MAHLIFE.NS is in Weinstein Stage 2 — the advancing phase. The 200-day moving average is trending upward, price is holding above all key moving averages, and the structure reflects institutional accumulation. This is the only stage where position traders should hold capital deployed in this instrument.

Relative Strength Rating

64 Stronger than 64% of the NSE universe
↓ Declining over 13 weeks

Structural Analysis

Mahindra Lifespace Developers Limited is currently trading 2.0% above its 50-day moving average, with Weinstein Stage 2 confirmed by the moving average hierarchy.

The Minervini SEPA audit finds 6 of 8 parameters confirmed. The parameter(s) not confirmed: 150 DMA above 200 DMA, RS Rating ≥70.

Sanjaya's Reading

The Witness Speaks

Mitra, main dekh raha hoon Mahindra Lifespace Developers Limited ko — 6 criteria poore hain aath mein se.

Weinstein Stage 2 mein hai yeh instrument. कसौटी के करीब.

This is a static snapshot

This audit was generated from NSE closing data on 21 August 2026. Run a live audit with real-time data, animated criteria reveals, and Sanjaya's full narration.

Run a Live Audit — Free →

Free tier includes Nifty 50 stocks · Pro unlocks full NSE universe

Frequently Asked Questions

Does MAHLIFE pass the Minervini SEPA criteria?

MAHLIFE (Mahindra Lifespace Developers Limited) currently meets 6 of 8 Minervini SEPA parameters. MAHLIFE currently meets 6 of 8 Minervini SEPA parameters. The parameter(s) not confirmed: 150 DMA above 200 DMA, RS Rating ≥70.

What is the Weinstein Stage Analysis for MAHLIFE?

MAHLIFE is currently in Weinstein Stage 2. MAHLIFE.NS is in Weinstein Stage 2 — the advancing phase. The 200-day moving average is trending upward, price is holding above all key moving averages, and the structure reflects institutional accumulation. This is the only stage where position traders should hold capital deployed in this instrument.

Is MAHLIFE structurally aligned for position trading?

The Kasauti verdict for MAHLIFE is कसौटी के करीब (Close to Criteria). The Kasauti verdict for MAHLIFE.NS is कसौटी के करीब — Close to Criteria. With 6 of 8 criteria met, the primary area to monitor is: 150 DMA above 200 DMA, RS Rating ≥70. This is a structural methodology assessment only — not a recommendation to deploy or exit capital. This is a structural methodology assessment only — not a recommendation to deploy or exit capital.

Methodology Assessment Disclaimer: This page presents a systematic structural audit of MAHLIFE against methodology parameters derived from the published works of Mark Minervini and Stan Weinstein. All data is sourced from NSE end-of-day prices. This content is for educational and analytical purposes only. Kasauti™ does not provide investment advice, stock recommendations, or capital deployment directives. Always conduct independent research and consult a SEBI-registered investment adviser before making any financial decisions.